Showing 961 - 980 results of 1,660 for search '"Dermatology"', query time: 0.06s Refine Results
  1. 961
  2. 962
  3. 963
  4. 964
  5. 965
  6. 966
  7. 967
  8. 968
  9. 969

    Assessing the Short-Term Efficacy and Safety of Guselkumab for Moderate-to-Severe Plaque Psoriasis: Meta-Analysis of Randomized Controlled Trials by Jing Yang, Zongming Wang, Xilin Zhang

    Published 2020-01-01
    “…The results indicated that guselkumab had better efficacy than placebo or adalimumab for Psoriasis Area and Severity Index score reductions from baseline of 75% (PASI 75) (OR=61.37, 95% CI=31.15 to 120.91; OR=3.08, 95% CI=2.35 to 4.06), Investigator’s Global Assessment scores of 0 or 1 (IGA 0/1) (OR=65.75, 95% CI=45.54 to 94.95; OR=2.79, 95% CI=2.17 to 3.59), and Dermatology Life Quality Index scores of 0 or 1 (DLQI 0/1) (OR=29.64, 95% CI=18.80 to 46.73; OR=1.86, 95% CI=1.50 to 2.31). …”
    Get full text
    Article
  10. 970
  11. 971
  12. 972
  13. 973
  14. 974
  15. 975
  16. 976
  17. 977
  18. 978
  19. 979
  20. 980